Abstract
Dihydrofolate reductase inhibitors, such as pyrimethamine, are known to have synergistic effects with sulfonamides. Four new solid forms combining pyrimethamine and sulfathiazole, one cocrystal (pyrimethamine-sulfathiazole (1:1)) and three solvated salt cocrystals (in which pyrimethamine and sulfathiazole are in a 1:2 molar ratio), are determined and characterized. Desolvation of the salt cocrystals leads to either a physical mixture of the starting compounds or the formation of the cocrystal (1:1) with an excess of sulfathiazole. The pyrimethamine sulfathiazole binary phase diagram was determined, which reveals that the pyrimethamine-sulfathiazole (1:2) composition point corresponds to a metastable eutectic. Obtaining this metastable eutectic as a pure powder is therefore rather difficult since it converts to a stable mixture of the (1:1) cocrystal + sulfathiazole. The abovementioned drug-drug multicomponent systems are characterized in terms of thermal stability (by TGA/DSC) and solubility. Both pyrimethamine-sulfathiazole (1:1) cocrystal and pyrimethamine-sulfathiazole (1:2) ethanol-solvated salt cocrystal result in an increase of the parent drugs’ solubility.
Original language | English |
---|---|
Pages (from-to) | 7811-7820 |
Number of pages | 10 |
Journal | Crystal Growth and Design |
Volume | 23 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Nov 2023 |
Externally published | Yes |
Fingerprint
Dive into the research topics of 'Salt and Cocrystals Combining Sulfathiazole with Pyrimethamine'. Together they form a unique fingerprint.Press/Media
-
Study Findings on Antimalarial Agents Are Outlined in Reports from University of Namur (Salt and Cocrystals Combining Sulfathiazole With Pyrimethamine)
5/12/23
1 item of Media coverage
Press/Media: Expert Comment